| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |